Ubiquilin1 represses migration and epithelial-to-mesenchymal transition of human non-small cell lung cancer cells

Oncogene

Volumn 34, Issue 13, 2015, Pages 1709-1717

  Shah, P P ^a   Lockwood, W W ^b   Saurabh, K ^a   Kurlawala, Z ^a,c   Shannon, S P ^a   Waigel, S ^a   Zacharias, W ^a,c   Beverly, L J ^a,c  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CARRIER PROTEIN; CDC48 PROTEIN; CELL CYCLE PROTEIN; HOMEODOMAIN PROTEIN; TRANSCRIPTION FACTOR; UBQLN1 PROTEIN, HUMAN; ZEB1 PROTEIN, HUMAN;

CELL MOTION; ENDOPLASMIC RETICULUM STRESS; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; LUNG TUMOR; NON SMALL CELL LUNG CANCER; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; TUMOR INVASION;

ADENOSINE TRIPHOSPHATASES; CARCINOMA, NON-SMALL-CELL LUNG; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; ENDOPLASMIC RETICULUM STRESS; EPITHELIAL-MESENCHYMAL TRANSITION; HOMEODOMAIN PROTEINS; HUMANS; LUNG NEOPLASMS; NEOPLASM INVASIVENESS; TRANSCRIPTION FACTORS;

EID: 84898525721     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2014.97     Document Type: Article

References (32)

1. Lim PJ, Danner R, Liang J, Doong H, Harman C, Srinivasan D, et al. Ubiquilin and p97/VCP bind erasin, forming a complex involved in ERAD. J Cell Biol 2009; 187: 201-217.
2. Lu A, Hiltunen M, Romano DM, Soininen H, Hyman BT, Bertram L, et al. Effects of ubiquilin 1 on the unfolded protein response. J Mol Neurosci 2009; 38: 19-30.
3. Kim H, Kim HY, Choi MR, Hwang S, Nam KH, Kim HC, et al. Potentiation of amyotrophic lateral sclerosis (ALS)-associated TDP-43 aggregation by the proteasome-targeting factor, ubiquilin 1. J Biol Chem 2009; 284: 8083-8092.
4. Arias-Vásquez A, de Lau L, Pardo L, Liu F, Feng BJ, Bertoli-Avella A, et al. Relationship of the ubiquilin 1 gene with Alzheimer's and Parkinson's disease and cognitive function. Neurosci Lett 2007; 424: 1-5.
5. Olzmann JA, Li L, Chin LS. Aggresome formation and neurodegenerative diseases: therapeutic implications. Curr Med Chem 2008; 15: 47-60.
6. Rutherford NJ, Lewis J, Clippinger AK, Thomas MA, Adamson J, Cruz PE, et al. Unbiased screen reveals ubiquilin-1 and-2 highly associated with huntingtin inclusions. Brain Res 2013; 1524: 62-73.
7. Beverly LJ, Lockwood WW, Shah PP, Erdjument-Bromage H, Varmus H. Ubiquitination, localization, and stability of an anti-apoptotic BCL2-like protein, BCL2L10/BCLb, are regulated by ubiquilin1. Proc Natl Acad Sci USA 2012; 109: E119-E126.
8. Chen G, Wang X, Yu J, Varambally S, Yu J, Thomas DG, et al. Autoantibody profiles reveal ubiquilin 1 as a humoral immune response target in lung adenocarcinoma. Cancer Res 2007; 67: 3461-3467.
9. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119: 1420-1428.
10. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871-890.
11. Zeisberg M, Neilson EG. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 2009; 119: 1429-1437.
12. Iwatsuki M, Mimori K, Yokobori T, Ishi H, Beppu T, Nakamori S, et al. Epithelialmesenchymal transition in cancer development and its clinical significance. Cancer Sci 2010; 101: 293-299.
13. Liu Y. New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol 2010; 21: 212-222.
14. Lilley BN, Ploegh HL. A membrane protein required for dislocation of misfolded proteins from the ER. Nature 2004; 429: 834-840.
15. Wójcik C, Rowicka M, Kudlicki A, Nowis D, McConnell E, Kujawa M, et al. Valosincontaining protein (p97) Is a regulator of endoplasmic reticulum stress and of the degradation of N-end rule and ubiquitin-fusion degradation pathway substrates in mammalian cells. Mol Biol Cell 2006; 17: 4606-4618.
16. Bevilacqua E, Wang X, Majumder M, Gaccioli F, Yuan CL, Wang C, et al. eIF2-? phosphorylation tips the balance to apoptosis during osmotic stress. J Biol Chem 2010; 285: 17098-17111.
17. Wang Q, Li L, Ye Y. Regulation of retrotranslocation by p97-associated deubiquitinating enzyme ataxin-3. J Biol Chem 2006; 174: 963-971.
18. Soetandyo N, Wang Q, Ye Y, Li L. Role of intramembrane charged residues in the quality control of unassembled T-cell receptor alpha-chains at the endoplasmic reticulum. J Cell Sci 2010; 123: 1031-1038.
19. Etienne-Manneville S, Hall A. Rho GTPases in cell biology. Nature 2002; 420: 629-635.
20. Shah PP, Fong MY, Kakar SS. PTTG induces EMT through integrin ?V?3-focal adhesion kinase signaling in lung cancer cells. Oncogene 2011; 31: 3124-3135.
21. Oyanagi J, Ogawa T, Sato H, Higashi S, Miyazaki K. Epithelial-mesenchymal transition stimulates human cancer cells to extend microtubule-based invasive protrusions and suppresses cell growth in collagen gel. PLoS ONE 2012; 7: e53209.
22. Grooteclaes ML, Frisch SM. Evidence for a function of CtBP in epithelial gene regulation and anoikis. Oncogene 2000; 19: 3823-3828.
23. Thiery JP. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 2003; 15: 740-746.
24. Acloque H, Adams MS, Fishwick K, Bronner-Fraser M, Nieto MA. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest 2009; 119: 1438-1449.
25. Nurwidya F, Takahashi F, Murakami A, Takahashi K. Epithelial mesenchymal transition in drug resistance and metastasis of lung cancer. Cancer Res Treat 2012; 244: 151-156.
26. Keshamouni VG, Michailidis G, Grasso CS, Anthwal S, Strahler JR, Walker A, et al. Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype. J Proteome Res 2006; 5: 1143-1154.
27. Christiansen JJ, Rajasekaran AK. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res 2006; 66: 8319-8326.
28. Vandewalle C, Van Royb F, Berxa G. The role of the ZEB family of transcription factors in development and disease. Cell Mol Life Sci 2009; 66: 773-787.
29. Dohadwala M, Yang SC, Luo J, Sharma S, Batra RK, Huang M, et al. Cyclooxygenase-2-dependent regulation of E-cadherin: rostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer. Cancer Res 2006; 66: 5338-5345.
30. Zhang GJ, Zhou T, Tian HP, Liu ZL, Xia SS. High expression of ZEB1 correlates with liver metastasis and poor prognosis in colorectal cancer. Oncol Lett 2013; 5: 564-568.
31. Shen A, Zhang Y, Yang H, Xu R, Huang G. Overexpression of ZEB1 relates to metastasis and invasion in osteosarcoma. J Surg Oncol 2012; 105: 830-834.
32. Kamiya T, Obara A, Hara H, Inagaki N, Adachi T. ER stress inducer, thapsigargin, decreases extracellular-superoxide dismutase through MEK/ERK signaling cascades in COS7 cells. Free Radical Res 2011; 45: 692-698.